Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 501668839

SPATA22 Mouse anti-Human, Clone: OTI2B1, lyophilized, TrueMAB™
SDP

Catalog No. 501668839
Encompass_Preferred
Change view
Click to view available options
Quantity:
100 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
50-166-8839 100 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 50-166-8839 Supplier OriGene Supplier No. CF808417
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

Reconstitute with PBS (pH 7.3) and recommend to perform another round of desalting process using Product No. 7KMWCO

SPATA22 is highly expressed in adult testis. The specific function of SPATA22 is not yet known.

Specifications

Antigen SPATA22
Applications Western Blot
Classification Monoclonal
Clone OTI2B1
Conjugate Unconjugated
Formulation PBS with 8% trehalose and no preservative; pH 7.3
Gene SPATA22
Gene Accession No. Q8NHS9
Gene Alias NYD-SP20, NYDSP20
Gene Symbols SPATA22
Host Species Mouse
Immunogen Full length human recombit protein of human SPATA22 produced in E.coli.
Purification Method Affinity Chromatography
Quantity 100 μg
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 84690
Target Species Human
Content And Storage -20° C, Avoid Freeze/Thaw Cycles
Product Type Antibody
Form Lyophilized
Isotype IgG2b
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.